A late-stage melanoma vaccine report that was posted online and quickly pulled is driving a violent repricing in Moderna ...

It has been a volatile year for the biotech.

Pfizer PFE will announce its third-quarter 2026 earnings on Nov. 3, and investors will be watching the performance of its oncology business closely, as the segment generates nearly 27% of the ...

Targeted Formulations' in the Context of Japanese Clinical PracticeThe key point of this news is the update of antigens to match the circulating virus. However, it is necessary to distinguish between ...

About 9% of adults hospitalized with RSV died in the hospital or within 30 days of discharge, according to preliminary data ...

MRNA expands beyond COVID-19 with new RSV, flu and combination vaccines, but fierce competition could challenge its efforts ...

HHS says vaccine-safety studies were withdrawn because their conclusions were not supported by the data, but the unpublished ...

Shah Capital has ended its attempts to exert influence over vaccine developer Novavax, bringing more than years of activism ...

AB-101 is a proprietary oral PD-L1 inhibitor that has the potential to activate patients’ hepatitis B virus (“HBV”)-specific immune response by inhibiting PD-L1. AB-101 has completed a Phase 1a/1b ...

A few months ago I sat through a marketing plan presentation that could have been delivered, almost word for word, in 1975.

A melanoma vaccine data leak wiped $24bn off Moderna before its Madrid presentation, despite a statistically strong Phase 3 ...

Get Clinical Trial News on Telangana Today, Clinical Trial latest news, Clinical Trial news, | Telangana Today ...